48 CFR § 27.204-1 - 27.204-1 Use of patented technology under the United States-Mexico-Canada Agreement.

---
identifier: "/us/cfr/t48/s27.204-1"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "48 CFR § 27.204-1 - 27.204-1   Use of patented technology under the United States-Mexico-Canada Agreement."
title_number: 48
title_name: "Federal Acquisition Regulations System"
section_number: "27.204-1"
section_name: "27.204-1   Use of patented technology under the United States-Mexico-Canada Agreement."
chapter_number: 1
chapter_name: "FEDERAL ACQUISITION REGULATION"
subchapter_number: "E"
subchapter_name: "GENERAL CONTRACTING REQUIREMENTS"
part_number: "27"
part_name: "PATENTS, DATA, AND COPYRIGHTS"
positive_law: false
currency: "2026-03-24"
last_updated: "2026-03-24"
format_version: "1.1.0"
generator: "[email protected]"
authority: "40 U.S.C. 121(c); 10 U.S.C. chapter 4 and 10 U.S.C. chapter 137 legacy provisions (see 10 U.S.C. 3016); and 51 U.S.C. 20113."
regulatory_source: "72 FR 63049, Nov. 7, 2007, unless otherwise noted."
cfr_part: "27"
---


# 27.204-1 27.204-1   Use of patented technology under the United States-Mexico-Canada Agreement.

When questions arise with regard to use of patented technology under the United States-Mexico-Canada Agreement, the contracting officer should consult with legal counsel. Note that Article 20.6(a) of the Agreement discusses public health and pharmaceuticals.

[87 FR 73892, Dec. 1, 2022]